ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Japan looks to send surplus AstraZeneca shots to Taiwan

Tokyo holds talks with drugmaker to eliminate no-transfers clause

A doctor receives a dose of the AstraZeneca vaccine in Taoyuan, Taiwan.   © Reuters

TOKYO -- Japan has entered into talks with AstraZeneca to supply a portion of its share of the company's coronavirus vaccine to Taiwan as the island struggles with a spike in cases.

Japan's agreement with AstraZeneca for 120 million doses of the two-shot vaccine includes a clause barring vaccines from being transferred to other destinations -- a stipulation found in many COVID-19 vaccine contracts. The health ministry is negotiating with AstraZeneca to modify the contract to allow shipments to Taiwan.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more